Streptococcal Group B Infection
Symptoms, Doctors, Treatments, Advances & More

Streptococcal Group B Infection Overview

Save information for later
Sign Up

Learn About Streptococcal Group B Infection

What is the definition of Streptococcal Group B Infection?
Group B streptococcus is a blood infection (septicemia) caused by the bacterium, Streptococcus agalactiae, which affects newborn babies. The infection is categorized into two syndromes: 1) early onset (<7 days old) and 2) late onset (7-90 days old). The infection can be caused when the baby moves through the birth canal (early onset), or the baby can become infected after birth through contact with carriers of the bacteria (late onset). Both syndromes can develop into pneumonia and meningitis.
What are the symptoms of Streptococcal Group B Infection?
Symptoms of Group B streptococcal infection in the newborn can include appearing anxious or stressed, blue skin (cyanosis), breathing difficulties, fast or slow heart rate, lethargy, pale, cold skin, poor feeding, and a low or high temperature.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Streptococcal Group B Infection?
The main treatment for Group B streptococcal infection in the newborn is intravenous (IV) antibiotics. Other treatments can include breathing support, intravenous fluids, treatment of shock, correction of blood clotting abnormalities, oxygen therapy, and, in severe cases, the use of a pump to circulate blood through an artificial lung (extracorporeal membrane oxygen).
Who are the top Streptococcal Group B Infection Local Doctors?
Elite in Streptococcal Group B Infection
Kirsty Le Doare
Elite in Streptococcal Group B Infection
Kirsty Le Doare
Referral may be required
St. George's University Of London, 
London, ENG, GB 

Kirsty Le Doare practices practicing medicine in London, United Kingdom. Ms. Le Doare is rated as an Elite expert by MediFind in the treatment of Streptococcal Group B Infection. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Streptococcal Group B Infection, Neonatal Sepsis, Strep Throat, and Meningitis.

Elite in Streptococcal Group B Infection
Dr. David Aronoff
Infectious Disease
Elite in Streptococcal Group B Infection
Dr. David Aronoff
Infectious Disease
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
317-944-5000
Languages Spoken:
English
See accepted insurances

David Aronoff is an Infectious Disease provider practicing medicine in Indianapolis, Indiana. Dr. Aronoff is rated as an Elite provider by MediFind in the treatment of Streptococcal Group B Infection. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Streptococcal Group B Infection, Strep Throat, Sepsis, and Pneumonia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Streptococcal Group B Infection
Shabir A. Madhi
Elite in Streptococcal Group B Infection
Shabir A. Madhi
Referral may be required
Johannesburg, GT, ZA 

Shabir Madhi practices practicing medicine in Johannesburg, South Africa. Mr. Madhi is rated as an Elite expert by MediFind in the treatment of Streptococcal Group B Infection. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Streptococcal Group B Infection, Strep Throat, Parainfluenza, and Flu.

View All Doctors
What are the latest Streptococcal Group B Infection Clinical Trials?
A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS
A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS
Enrollment Status: Recruiting
Publish Date: June 09, 2026
Intervention Type: Biological
Study Phase: Phase 3

Summary: BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their babies. This study is seeking healthy pregnant participants: * aged 49 or younger who can join. * between 24 and 36 weeks of gestation (Gestational age is a medical term used to describe how far along ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Development of Group B Streptococcus Quality Assurance Panel for the GASTON Multiplex Anti-CPS IgG Immunoassay.
Development of Group B Streptococcus Quality Assurance Panel for the GASTON Multiplex Anti-CPS IgG Immunoassay.
Enrollment Status: Recruiting
Publish Date: May 01, 2026
Intervention Type: Other

Summary: Collection of serum from women not living with HIV, who received the GBS6 vaccine in the a placebo-controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants (GBS6) Clinical Trial in Kampala, Uganda, for the Development of Group B Streptococcus quality assurance panel for the GASTON...

View All Clinical Trials